WallStreetZenWallStreetZen

NASDAQ: OKUR
Onkure Therapeutics Inc Stock Ownership - Who owns Onkure Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Onkure Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Nicholas A. SaccomanoPresident and CEO2026-06-2286$4.40
$378.06Sell
Jason A. LeveroneChief Financial Officer2026-06-22303$4.40
$1.33kSell
Nicholas A. SaccomanoPresident and CEO2026-03-2386$4.16
$357.50Sell
Jason A. LeveroneChief Financial Officer2026-03-23301$4.16
$1.25kSell
Jason A. LeveroneChief Financial Officer2025-12-22302$2.97
$896.34Sell
Nicholas A. SaccomanoPresident and CEO2025-12-2287$2.97
$258.22Sell
Nicholas A. SaccomanoPresident and CEO2025-09-2288$2.62
$230.82Sell
Jason A. LeveroneChief Financial Officer2025-09-22303$2.62
$794.77Sell

1 of 1

OKUR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when OKUR insiders and whales buy or sell their stock.

OKUR Shareholders

What type of owners hold Onkure Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
New Enterprise Associates 15 LP11.82%4,785,494$14.36MInsider
Ai Biotechnology LLC9.87%3,998,332$11.99MInsider
Braden Michael Leonard9.64%3,905,210$11.72MInsider
Holdings A. Novo8.22%3,330,337$9.99MInsider
Acorn Bioventures LP7.01%2,839,674$8.52MInsider
Rivervest Venture Fund III LP5.95%2,409,220$7.23MInsider
Niall Odonnell5.40%2,188,713$6.57MInsider
Bali Muralidhar5.12%2,073,957$6.22MInsider
Cormorant Asset Management LP4.48%1,813,439$5.44MInsider
Acorn Bioventures 2 LP2.79%1,129,730$3.39MInsider

1 of 3

OKUR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OKUR0.09%72.59%Net SellingNet Selling
INO0.03%30.13%Net Selling
CLLS0.01%0.00%
VTVT0.00%100.00%Net Buying
CBUS0.02%64.61%Net Buying
View Top Biotech Stocks

Onkure Therapeutics Stock Ownership FAQ

Who owns Onkure Therapeutics?

Onkure Therapeutics (NASDAQ: OKUR) is owned by 0.09% institutional shareholders, 72.59% Onkure Therapeutics insiders, and 27.33% retail investors. New Enterprise Associates 15 LP is the largest individual Onkure Therapeutics shareholder, owning 4.79M shares representing 11.82% of the company. New Enterprise Associates 15 LP's Onkure Therapeutics shares are currently valued at $14.02M.

If you're new to stock investing, here's how to buy Onkure Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.